Acting CDC Director Praises FDA Commissioner Marty Makary Amid Ouster Rumors
As whispers swirl about the possible removal of FDA Commissioner Marty Makary, Acting CDC Director Dr. Jay Bhattacharya steps up with high praise, calling Makary “amazing” and a “good friend.” But Bhattacharya dodges the key question: does Makary still have President Trump’s backing?
The latest drama brewing inside the Trump administration’s health agencies centers on FDA Commissioner Marty Makary, whose job now appears precarious amid reports of a potential ouster. Yet, in a recent interview with CNN’s Jake Tapper, Acting CDC Director Dr. Jay Bhattacharya offered an unreserved endorsement, calling Makary “an absolutely amazing scholar,” “an absolutely amazing surgeon,” and “an absolutely amazing FDA Commissioner.”
Despite the glowing accolades, Bhattacharya was careful to avoid confirming whether Makary still enjoys President Trump’s confidence. “You’d have to ask the president,” Bhattacharya said, sidestepping any direct answer.
Makary’s tenure at the FDA has been contentious, with critics accusing the Trump administration of politicizing the agency and undermining public health expertise. His close ties to Trump allies and controversial stances on COVID-19 policies have fueled speculation that he may soon be replaced as part of a broader shakeup.
Bhattacharya’s public defense does little to quell rumors of internal discord. It instead raises questions about how much influence political loyalty versus scientific credibility holds in the administration’s health leadership decisions.
For a White House already mired in accusations of corruption and authoritarian overreach, the uncertainty surrounding one of the nation’s top health officials underscores a broader pattern: loyalty to Trump often trumps institutional integrity and expertise.
We will be watching closely as this story develops, because who leads the FDA matters deeply for public health and democratic accountability. Stay tuned.
Comments (0)
No comments yet. Be the first to share your thoughts.
Sign in to leave a comment.